Design of dual acting anticonvulsant-antimuscarinic succinimide and hydantoin derivatives

Add time:07/31/2019    Source:sciencedirect.com

A series of 4-dialkylamino-2-butynyl-succinimide and -hydantoin derivatives were designed containing pharmacophoric elements for dual acting anticonvulsant and antimuscarinic activity. Potent anticonvulsant agents were identified with an extremely rapid onset of protective activity. Succinimides 13 and 13 exhibited ED50 values of 20 and 9.6 mg/kg 10 minutes after administration in the MES seizure model and also exhibited good binding affinity for the M1 muscarinic receptor.

We also recommend Trading Suppliers and Manufacturers of N-(2-Propynyl)succinimide (cas 10478-33-8). Pls Click Website Link as below: cas 10478-33-8 suppliers

Prev:Bubble-point measurement for the binary mixture of PROPARGYL ACRYLATE (cas 10477-47-1) and propargyl methacrylate in supercritical carbon dioxide
Next:Reaction of trifluoromethylated ynamines with halogenating agents: a convenient access to 2-halo- and 2,2-dihalo-3,3,3-trifluoropropanamides)